Romidepsin: evidence for its potential use to manage previously treated cutaneous T cell lymphoma.
about
Romidepsin: evidence for its potential use to manage previously treated cutaneous T cell lymphoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Romidepsin: evidence for its p ...... ted cutaneous T cell lymphoma.
@ast
Romidepsin: evidence for its p ...... ted cutaneous T cell lymphoma.
@en
Romidepsin: evidence for its p ...... ted cutaneous T cell lymphoma.
@nl
type
label
Romidepsin: evidence for its p ...... ted cutaneous T cell lymphoma.
@ast
Romidepsin: evidence for its p ...... ted cutaneous T cell lymphoma.
@en
Romidepsin: evidence for its p ...... ted cutaneous T cell lymphoma.
@nl
prefLabel
Romidepsin: evidence for its p ...... ted cutaneous T cell lymphoma.
@ast
Romidepsin: evidence for its p ...... ted cutaneous T cell lymphoma.
@en
Romidepsin: evidence for its p ...... ted cutaneous T cell lymphoma.
@nl
P2093
P2860
P356
P1433
P1476
Romidepsin: evidence for its p ...... ted cutaneous T cell lymphoma.
@en
P2093
Brian Poligone
Catherine Chung
P2860
P356
10.2147/CE.S9084
P407
P577
2010-12-22T00:00:00Z